Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.
about
Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@en
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@en-gb
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@nl
type
label
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@en
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@en-gb
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@nl
prefLabel
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@en
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@en-gb
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@nl
P2093
P2860
P50
P356
P1154
2-s2.0-84978628197
P1433
P1476
Reduced genomic tumor heteroge ...... ith esophageal adenocarcinoma.
@en
P2093
Askar Obulkasim
Christian Benner
Gerrit A Meijer
Hendrik F van Essen
Imran Inam
Mark A van de Wiel
Nicolas P West
Ruth Langley
Sally Stenning
William Allum
P2860
P304
44084-44095
P356
10.18632/ONCOTARGET.9857
P407
P5530
P577
2016-06-06T00:00:00Z
P6179
1009264292